Scott H Greenwald, PhD
Pierce Lab/Ocular Genomics Institute
Scott Greenwald graduated from the University of Pennsylvania with a degree in the biological basis of behavior before joining Second Sight Medical Products to research the perceptual effects of artificial retinal stimulation in patients with advanced retinitis pigmentosa. He went on to study cone photoreceptor dysfunction associated with inherited retinal diseases at the University of Washington where he earned a PhD in neurobiology.
Scott became a member of the Ocular Genomics Institute at MEEI in 2013. He is investigating the role of the NMNAT1 enzyme in retinal cell metabolism and the mechanisms by which mutations in the NMNAT1 gene cause early-onset blindness.
Research Areas: Retina, cone photoreceptors, color vision, retinal prostheses, mouse models, gene therapy, human psychophysics
Boston, MA 02114